Evidence of particulate matter has prompted Baxter to recall 795,000 individual units of 5% dextrose and 0.9% sodium chloride intravenous solutions.

The presence of foreign matter has prompted Baxter International to recall 3 lots of 0.9% sodium chloride and 1 lot of potassium chloride IV solutions, about 940,000 individual units in total.

As a result, San Diego-based Wallcur, a company that makes these simulation products sold in various sizes as Practi-0.9% sodium chloride IV solution, issued a voluntary recall earlier this month.

Lower use of chloride in intravenous fluids for critically ill patients associated with decreased risk of kidney injury Date: October 16, 2012 Source: American Medical Association (AMA) Summary ...

The FDA on March 21 shared recommendations for healthcare organizations to conserve prefilled 0.9 percent sodium chloride intravenous lock/flush syringes amid a national shortage. 1. Use ...

Contrast-associated AKI occurred in 9.5% and 8.3% of the IV sodium bicarbonate and IV sodium chloride groups, respectively, and 9.1% vs 8.7% of the acetylcysteine and placebo groups, respectively.

Based on feedback from the FDA, Protara intends to assess the safety and efficacy of IV Choline Chloride in THRIVE-3, a seamless registrational Phase 2b/3 trial with dose confirmation followed by ...

LAKE ZURICH, Ill.-- (BUSINESS WIRE)--Fresenius Kabi announced today it has introduced two new presentations of Calcium Gluconate in Sodium Chloride Injection in the United States in the company ...